Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898638 · ClinicalTrials.gov registry record
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
A clinical trial of Head and Neck Cancer, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- 8,000
- Enrollment target
- 4
- Study locations
NCT00898638: Recruiting study of Head and Neck Cancer, sponsored by Vanderbilt University Medical Center.
NCT00898638 is a study of Head and Neck Cancer that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 8,000 participants, above the 229-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (3393% higher). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00898638, a study of Head and Neck Cancer, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- 8,000 participants
- Enrollment target
- 4
- Study locations
Study Summary
RATIONALE: Collecting and storing samples of tissue, saliva, and blood from patients with cancer and from healthy participants to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing tissue samples from patients with head and neck cancer and from healthy participants.
Primary Outcome
Collection of data for both groups from the Vanderbilt Otolaryngology Patient Intake questionnaire as well as the medical record, such as medical history, family history, and exposures to risk factors for cancer (tobacco and alcohol use), and results of tests related to diagnosis of tumor and treatment response (for tumor patients only).
Conditions Studied
Interventions
- OTHER biologic sample preservation procedure
- OTHER medical chart review
Study Locations (4)
Tennessee
- Vanderbilt-Ingram Cancer Center - Cool Springs - Nashville
- Vanderbilt-Ingram Cancer Center at Franklin - Nashville
- Veterans Affairs Medical Center - Nashville - Nashville
- Vanderbilt-Ingram Cancer Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,000 participants |
| Start Date | 2003-02-13 |
| Est. Completion | 2050-12 |
What NCT00898638 shows while recruiting
NCT00898638 is an observational study that tracks outcomes without assigning an intervention. Its 8,000 participants enrollment target places it among the larger protocols in the corpus, above the 229-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (3393% higher).
The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 2 interventions - of which biologic sample preservation procedure is the first listed.
NCT00898638 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00898638 about?
NCT00898638 is a clinical study titled "Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants". RATIONALE: Collecting and storing samples of tissue, saliva, and blood from patients with cancer and from healthy participants to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing tissue samples from patients with head and nec...
What is the current status of trial NCT00898638?
This trial is currently recruiting. The enrollment target is 8,000 participants. The study started on 2003-02-13. Estimated completion is 2050-12.
What conditions does trial NCT00898638 study?
This clinical trial studies the following conditions: Head and Neck Cancer.
What interventions are being tested in trial NCT00898638?
The interventions under investigation include: biologic sample preservation procedure (OTHER), medical chart review (OTHER).
Who is sponsoring clinical trial NCT00898638?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00898638 being conducted?
This trial has 4 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00898638's enrollment target sits among peer trials
8,000 2nd of 250 the highest of 250 other Head and Neck Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Head and Neck Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
3D Specimen Maps for RT Planning
RECRUITING
-
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
RECRUITING · Phase 1
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck
RECRUITING · NA
-
RAPA-201 Therapy of Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
- NCT02240862 · 8,000 participants
The CREST-2 Registry
- NCT03072927 · 8,000 participants
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
- NCT04075305 · 8,000 participants
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI